Skin Cancer Screening: Mole Checks, Self-Examination, and What the Evidence Supports

Skin cancer screening is a check of the whole skin surface in someone with no symptoms, looking for melanoma and the commoner non-melanoma cancers before they are noticed, and unlike bowel, breast, or cervical screening it is not offered to the whole population at a set age, because the evidence for doing that is incomplete. What the evidence does support is narrower and more useful: knowing whether you sit in the higher-risk group, understanding what a proper examination involves, and treating a changing mole as an appointment rather than a wait.

I came to this the way I came to most of this site, which is late and slightly embarrassed. After the blood pressure reading that started all of this, I went through the list of things I had been quietly ignoring, and near the top was a mole on my shoulder that I had been “keeping an eye on” for the better part of a decade without ever once looking at it properly. It turned out to be nothing. The point is that “keeping an eye on it” had meant doing nothing at all, which is not a screening strategy.

What skin cancer screening is looking for

Screening looks for two families of skin cancer, and they behave very differently. Non-melanoma skin cancers, mainly basal cell carcinoma and squamous cell carcinoma, are by far the more common: WHO puts them in the millions of new cases a year worldwide, and they are strongly tied to lifetime ultraviolet exposure ¹. Basal cell carcinoma almost never spreads and is usually cured by removal. Squamous cell carcinoma can spread if left, though it rarely does when treated early.

Melanoma is the minority case and the dangerous one. It accounts for a small share of skin cancers and the large majority of skin cancer deaths, because it can spread while still small. It is also the one where timing matters most: a thin melanoma removed early has a very high chance of cure, and that chance falls as the lesion grows deeper. Cancer overall is among the leading causes of death worldwide, and early detection is one of the two pillars WHO names alongside prevention ². Skin is one of the few organs where detection needs no scanner or blood test, which is what makes the screening question interesting rather than obvious.

The obvious question is why, given all that, nobody just checks everyone. The answer sits in the evidence, which is the next section.

Who is actually offered a regular check

No major evidence body recommends routine whole-body skin examination for every symptom-free adult; for people at higher risk, regular examination by a clinician is common practice and widely offered. The U.S. Preventive Services Task Force, reviewing the question again in 2023, concluded that the evidence is insufficient to say whether visual skin examination by a clinician in symptom-free adults does more good than harm, which is a statement of uncertainty, not a recommendation against ³. Population programmes in other countries have reached broadly similar positions: most do not invite everyone, and several run targeted or opportunistic checks instead.

That is a different situation from the general-population cancer screening programmes, where the trial evidence for benefit exists and the argument is about intervals and ages. For skin, the classic criteria for a screening programme, a common and serious condition, a detectable early stage, an accurate acceptable test, and evidence that early treatment changes the outcome, are met on several counts and unproven on the last one at population level ⁴.

Risk changes that calculation. The factors that put someone in the group where regular examination is commonly offered are well established:

• Fair skin that burns easily, with red or fair hair and light eyes at the top of the scale.
• A high mole count, often framed as more than 50 ordinary moles, or several atypical moles that are larger, irregular, or multi-coloured.
• A history of sunburn, particularly blistering burns in childhood or adolescence.
• Use of sunbeds, especially before the age of 30 or 35; IARC classifies UV-emitting tanning devices as carcinogenic to humans ¹.
• A first-degree relative (parent, sibling, or child) with melanoma.
• A previous skin cancer of any type, which is the single strongest predictor of another.
• A suppressed immune system, most notably after organ transplantation, where the risk of squamous cell carcinoma in particular rises many-fold.
• Long outdoor working life, or a childhood spent at high UV latitudes or altitudes.

One of these is worth mentioning to a clinician. Two or more, and a dermatologist will usually want to see you on a schedule. That is the group for whom “annual skin check” stops being an optional add-on and becomes a sensible line in a personal screening plan.

What a full skin examination involves

A clinician skin check is a visual examination of the entire skin surface, usually with a dermatoscope, and it takes about 10 to 20 minutes. You undress to underwear in a room with good light. The clinician works systematically, scalp to soles, including the places people never look: between toes, behind ears, the back, the buttocks, and under nails. A dermatoscope, a hand-held magnifier with polarised light, lets them see pigment structure beneath the surface, and trained use of it substantially improves accuracy over the naked eye. Anything of interest is measured and often photographed so it can be compared next time.

Where someone has many moles, total-body photography, sometimes marketed as mole mapping, records the whole skin in a set of standardised images. Its value is comparison rather than diagnosis: at the next visit, the question is not “does this look wrong” but “is this new or different”, which is a far easier question for both of you. For a person with a dozen moles and no risk factors, it produces a lot of images and little information; for someone with a hundred, it is the only realistic way to notice change.

If a lesion is suspicious, the usual step is to remove it under local anaesthetic and send it to a laboratory. That is diagnosis, not screening, and it is worth understanding the difference between the two before the appointment, because most people are surprised that the answer comes from a pathologist a week or two later rather than from the room. Most excised lesions turn out to be benign. That is the expected output of a cautious examiner, not a sign anything went wrong.

Checking your own skin

Self-examination means looking at your whole skin, about once a month is the interval charities commonly suggest, and knowing what your moles normally look like so that change stands out. Nobody has shown in a trial that self-examination reduces deaths from melanoma, but it is free, harmless, and it is how the majority of melanomas are in fact first noticed: by the person, or by a partner or a hairdresser who sees the back of the neck more often than its owner does.

The ABCDE rule is the standard memory aid. Asymmetry, where one half does not match the other. Border, irregular, ragged, or blurred. Colour, more than one shade, or an uneven mix of brown, black, red, white, or blue. Diameter, larger than about 6 mm, roughly the end of a pencil, though melanomas can be smaller when found. And Evolving, any change in size, shape, colour, elevation, or a new symptom such as itching, bleeding, or crusting.

The E is the letter that matters most, and it is joined by the “ugly duckling” sign: a mole that simply does not look like the rest of your moles, regardless of the other letters. Most people’s moles resemble each other, and an outlier is worth a second look even if it is small and one colour.

The essential distinction: a mole that has changed is no longer a screening matter. It is a symptom, and it needs a clinician now, not a place on next year’s list. Screening is for the skin that looks fine.

The harms side of the ledger

Skin screening can cause harm through unnecessary biopsies, scarring, anxiety, and overdiagnosis, and the harm scales with how many low-risk people are examined. This is the same arithmetic that runs through every screening test on this site, described in the harms of over-testing and overdiagnosis: the more closely you look at people who are probably well, the more you find that probably did not matter.

For skin the specific concern is overdiagnosis of very early melanoma. In several countries, melanoma diagnoses have risen several-fold over recent decades while deaths from melanoma have moved far less, a divergence that is hard to explain by earlier detection of dangerous cancers alone and is consistent with a share of diagnoses being lesions that would never have progressed. Each of those still carries a cancer label, an excision, a scar, and years of follow-up. None of this argues against examining people at risk. It argues against examining everyone, which is exactly where the evidence bodies have landed.

The practical consequence for a reader deciding whether to book: a skin check for a low-risk adult with no concerning moles is not dangerous, but its most likely outputs are reassurance and, occasionally, a biopsy of something harmless. For a higher-risk adult, the same examination is one of the better value items on any screening menu.

Prevention beats detection

Ultraviolet radiation is the dominant preventable cause of both melanoma and non-melanoma skin cancer, and reducing exposure does more than any examination can ¹. Shade in the middle of the day, clothing and a hat, sunglasses that block UV, broad-spectrum sunscreen on skin that cannot be covered, and no sunbeds at any age are the levers WHO names, and a large share of skin cancers are attributable to UV exposure that could have been avoided.

The early years carry disproportionate weight. Sunburn in childhood and adolescence appears to raise lifetime melanoma risk more than the same burn in adulthood, which is why protecting children is the highest-yield intervention in the whole field. That does not let adults off: cumulative exposure drives non-melanoma cancers, and a lifetime of outdoor work or weekend sun adds up.

Screening, early detection, and prevention are the three parts of one plan, and WHO frames them that way for cancer generally ⁵. For skin, prevention is the part that actually lowers your risk, self-checking is the part that catches change, and clinician examination is the part that earns its place in proportion to how much risk you carry. Where it sits alongside the broader habits that prevent disease is, for once, simple: it is one of the few where the advice fits on a hat.

This article is general information, not medical advice. Whether you need a regular skin examination, how often, and what any particular mole means are questions for a qualified clinician or dermatologist who can see your skin and knows your history.